-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FUVa8TdGypsruoZWwEu9cFGzM6CbMXxpMAqjCuWP5cuHEQkSqHEQTgX0WnSBxcNF ai537eDX1F/w2ZflUobvbg== 0001209191-05-006663.txt : 20050203 0001209191-05-006663.hdr.sgml : 20050203 20050203161752 ACCESSION NUMBER: 0001209191-05-006663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050201 FILED AS OF DATE: 20050203 DATE AS OF CHANGE: 20050203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN NOSTRAND ROBERT L CENTRAL INDEX KEY: 0001225198 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 05573573 BUSINESS ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S. SERVICE RD. CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-02-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001225198 VAN NOSTRAND ROBERT L C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP, & Chief Financial Officer Common Stock 2005-02-01 4 M 0 155 7.094 A 5054 D Common Stock 2005-02-01 4 M 0 2095 21.55 A 7149 D Common Stock 2005-02-01 4 S 0 301 65.00 D 6848 D Common Stock 2005-02-01 4 S 0 604 65.10 D 6244 D Common Stock 2005-02-01 4 S 0 301 65.15 D 5943 D Common Stock 2005-02-01 4 S 0 1044 65.16 D 4899 D Stock Option (Right to Buy) 7.094 2005-02-01 4 M 0 155 0.00 D 1997-12-10 2006-12-09 Common Stock 155 0 D Stock Option (Right to Buy) 21.55 2005-02-01 4 M 0 2095 0.00 D 2003-06-12 2012-06-11 Common Stock 2095 14705 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand 2005-02-03 -----END PRIVACY-ENHANCED MESSAGE-----